| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Metabolic system |
代谢系统 |
|
详细
|
| Screening model of gastrointestinal motility inhibitors |
胃肠动力抑制剂筛选模型 |
|
详细
|
| Myocardial injury protective agent screening model |
心肌损伤保护剂筛选模型 |
|
详细
|
| Screening model of renal protective agents |
肾功能保护剂筛选模型 |
|
详细
|
| Reproductive toxicity and reproductive ability evaluation; Gonadal growth evaluation; Histological sections of gonads; |
生殖毒性生殖能力评价;性腺生长评价;性腺病理组织切片; |
|
详细
|
| Gastrointestinal peristalsis function (autonomic nerve). |
胃肠蠕动功能（植物神经）。 |
|
详细
|
| inflammatory reaction |
炎症反应 |
|
详细
|
| Intestinal morphology; Intestinal peristalsis requires motor function. |
肠道形态学;肠蠕需动功能。 |
|
详细
|
| Carry out appropriate toxicity tests with experimental animals |
用实验动物进行适当的毒性试验 |
|
详细
|
| Genetically modified animal model |
遗传修饰动物模型 |
|
详细
|
| Apoptosis inhibitor screening model |
凋亡抑制剂筛选模型 |
|
详细
|
| Fat metabolism model |
脂肪代谢模型 |
|
详细
|
| Erythrocyte thrombosis model |
红细胞性血栓模型 |
|
详细
|
| Mouse bradycardia model |
小鼠心动过缓模型 |
|
详细
|
| Incidence of developmental toxicity and teratogenicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding) |
发育毒性与致畸性（脑、下颚、眼、肾脏、肠道、躯干/尾/脊髓/体节、身体着色、循环系统、身体水肿、出血）毒性发生率 |
|
详细
|
| Behavior (touch response, movement influence, light and dark influence); |
行为学（触碰反应、运动影响、光暗影响）; |
|
详细
|
| Behavior |
行为学 |
|
详细
|
| Anaphylactic reaction |
类过敏反应 |
|
详细
|
| Animal model of depression |
抑郁动物模型 |
|
详细
|
| neurotoxicity |
神经毒性 |
|
详细
|
| Immunotoxicity |
免疫毒性 |
|
详细
|
| Preclinical drug experiment preclinical research (outsourcing entrusted experiment) |
药物临床前实验 临床前研究（外包委托实验） |
|
详细
|
| Efficacy evaluation model of drug efficacy evaluation system |
药物功效评价 系统 功效评价模型 |
|
详细
|
| Mitochondrial function |
线粒体功能 |
|
详细
|
| Protective model of vascular endothelial injury |
血管内皮损伤保护模型 |
|
详细
|
| Promoting tissue regeneration / wound healing |
促组织再生作用/伤口愈合 |
|
详细
|
| Embryotoxicity (OECD standard) |
胚胎毒性（OECD标准） |
|
详细
|
| Degree of liver degeneration; Yolk sac size. |
肝变性程度;卵黄囊大小。 |
|
详细
|
| Osteotoxicity |
骨毒性 |
|
详细
|
| Phenotypic observation |
表型观察 |
|
详细
|
| Induction model of high sugar and high fat diet |
高糖高脂饮食诱导模型 |
|
详细
|
| Screening model of antialcoholic agents |
解酒剂筛选模型 |
|
详细
|
| Screening model of angiogenesis promoters |
血管再生促进剂筛选模型 |
|
详细
|
| Cytochrome P450 analysis |
细胞色素P450分析 |
|
详细
|
| Cartilage injury model |
软骨损伤模型 |
|
详细
|
| apoptotic cell |
凋亡细胞 |
|
详细
|
| The incidence of renal capsule edema;. |
肾包膜水肿发生率;。 |
|
详细
|
| Ocular toxicity |
眼毒性 |
|
详细
|
| Mortality; Evaluation of median lethal concentration (LC50). |
死亡率;半数致死浓度（LC50）评价。 |
|
详细
|
| Screening model of P-glycoprotein inhibitors |
P-糖蛋白抑制剂筛选模型 |
|
详细
|
| Screening model of energy metabolism regulator |
能量代谢调节剂筛选模型 |
|
详细
|
| Induced qi stagnation and blood stasis thrombosis model |
诱导气滞血瘀型血栓模型 |
|
详细
|
| Liver kidney model |
肝肾模型 |
|
详细
|
| Cardiovascular toxicity heart rate; Heart rhythm; The incidence of pericardial edema; Incidence of bleeding; Incidence of changes in blood flow velocity; Incidence of thrombosis |
心血管毒性心率;心律;心包水肿发生率;出血发生率;血流速度变化的发生率;血栓发生率 |
|
详细
|
| Fluorescence signal intensity of apoptotic cells in central nervous system; |
中枢神经凋亡细胞荧光信号强度; |
|
详细
|
| Carcinogenicity (mice) |
致癌性（小鼠） |
|
详细
|
| Tryptase expression level (OD value); Anaphylactic reaction test. |
Tryptase表达水平（OD值）;类过敏反应检测。 |
|
详细
|
| Animal experiment of depression |
抑郁动物实验 |
|
详细
|
| Preclinical evaluation of cardiac drugs |
心脏药物临床前评价 |
|
详细
|
| Anti angiogenesis model |
抗血管形成模型 |
|
详细
|
| Cardio cerebrovascular |
心脑血管 |
|
详细
|
| PM2. 5. Screening model of drainage promoters |
PM2.5促排剂筛选模型 |
|
详细
|
| Screening model of bone development promoters |
骨骼发育促进剂筛选模型 |
|
详细
|
| The incidence of egg coagulation; No heart rate; Hatching rate; The incidence of no somite formation; Incidence of tail non separation; |
卵凝结发生率;无心跳发生率;孵化率;体节未形成发生率;尾部未分离发生率; |
|
详细
|
| Nephrotoxicity |
肾毒性 |
|
详细
|
| Bone mineral density (fluorescence signal intensity); Number of vertebrae. |
骨密度（荧光信号强度）;脊椎骨数量。 |
|
详细
|
| Median lethal concentration |
半数致死浓度 |
|
详细
|
| Should we experiment with animals |
应该用动物做实验吗 |
|
详细
|
| Skin irritation; Muscle texture; Quantification of skin apoptotic cells; Skin pigment changes. |
皮肤刺激;肌肉纹理;皮肤凋亡细胞定量;皮肤色素变化。 |
|
详细
|
| Safety evaluation |
安全性评价 |
|
详细
|
| Preclinical evaluation of antiviral research and development |
抗病毒研发临床前评价 |
|
详细
|
| Uric acid model |
尿酸模型 |
|
详细
|
| Intestinal digestive function |
肠道消化功能 |
|
详细
|
| Skeletal muscle |
骨骼肌肉 |
|
详细
|
| Screening model of therapeutic agents for osteoporosis |
骨质疏松症治疗剂筛选模型 |
|
详细
|
| Fluorescence signal intensity of apoptotic cells (AO staining, TUNEL staining) |
凋亡细胞荧光信号强度（AO染色、TUNEL染色） |
|
详细
|
| Audiotoxicity |
听毒性 |
|
详细
|
| Eye size; Ocular apoptotic cells; Ocular vascular area; Ocular histopathology. |
眼睛大小;眼部凋亡细胞;眼部血管面积;眼组织病理学。 |
|
详细
|
| Genotoxicity |
基因毒性 |
|
详细
|
| Induction model of caspase activity |
对Caspase活性的诱导作用模型 |
|
详细
|
| Pharmacodynamic evaluation model of slimming drugs |
减肥药药效评价模型 |
|
详细
|
| Drug screening model for the treatment of heart failure |
心衰治疗药物筛选模型 |
|
详细
|
| Screening model of hepatoprotective drugs |
保肝药筛选模型 |
|
详细
|
| Number of hematotoxic neutrophils; Number of macrophages; Number of red blood cells (signal intensity); Blood flow. |
血液毒性中性粒细胞数量;巨噬细胞数量;红细胞数量（信号强度）;血流量。 |
|
详细
|
| Peripheral motor nerve length; Incidence of brain degeneration; |
周围运动神经长度;脑变性发生率; |
|
详细
|
| Macrophage function |
巨噬细胞功能 |
|
详细
|
| Gastrointestinal toxicity |
胃肠道毒性 |
|
详细
|
| Why do experiments with animals |
用动物做实验的原因 |
|
详细
|
| Genetic engineering animal model |
遗传工程动物模型 |
|
详细
|
| mycoalert mycoplasma detection kit |
支原体检测试剂盒 |
|
详细
|
| Preclinical spinal cord injury experiment |
临床前脊髓损伤实验 |
|
详细
|
| Angiogenesis inhibitor screening |
血管形成抑制剂筛选 |
|
详细
|
| Hypolipidemic model |
降血脂模型 |
|
详细
|
| Platelet aggregation thrombosis model |
血小板聚集性血栓模型 |
|
详细
|
| Oxygen free radical (ROS) scavenger screening model |
氧自由基（ROs）清除剂筛选模型 |
|
详细
|
| Incidence of acute toxicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding) |
急性毒性（脑、下颚、眼、肾脏、肠道、躯干/尾/脊髓/体节、身体着色、循环系统、身体水肿、出血）毒性发生率 |
|
详细
|
| Vitellogenin (VTG) content detection; The expression of genes related to hypothalamic pituitary gonadal axis was detected. |
卵黄蛋白原（VTG）含量检测;下丘脑-垂体-性腺 轴线相关基因表达量检测。 |
|
详细
|
| Behavioral toxicity |
行为毒性 |
|
详细
|
| Number of neutrophils; Expression level of inflammatory factors. |
中性粒细胞数量;炎症因子表达水平。 |
|
详细
|
| Factors affecting animal models |
影响动物模型的因素 |
|
详细
|
| Drug evaluation and testing items (outsourcing entrusted experiment) |
药物评价检测项目（外包委托实验） |
|
详细
|
| Preclinical evaluation of reproductive toxicity |
生殖毒临床前评价 |
|
详细
|
| Spleen yang deficiency model |
脾阳虚模型 |
|
详细
|
| Intestinal mucus secretion function |
肠道粘液分泌功能 |
|
详细
|
| Analgesic drug screening |
镇痛药物筛选 |
|
详细
|
| Drug safety evaluation model index |
药物安全性评价 评价模型 指标 |
|
详细
|
| Hepatotoxicity (juvenile fish) |
肝毒性（幼鱼） |
|
详细
|
| Fluorescence signal intensity of hair cells |
毛细胞荧光信号强度 |
|
详细
|
| Skin toxicity |
皮肤毒性 |
|
详细
|
| Comet experiment; Genotoxicity evaluation. |
慧星实验;基因毒性评价。 |
|
详细
|